Our Partners
Drugs Testing Book
- Table of Contents
- Introduction
- Immunoassays and Their Screening
- An Overview Regarding the History of Immunoassays
- Basic Immunoassay Principles and Guidelines
- Variety of Immunoassays Used for Illicit Drug Testing Programs for workplaces
- Characteristics of an Immunoassay’s Performance
- Methodology Limitations
- Types and Mechanisms of Interference of Assays
- Sources of Interference
- Immunoassays and Their Application Regarding Workplace Drug Testing Programs
- Cutoff Ranges and Result Interpretation
- Selection and Troubleshooting of Immunoassays
- Summary
- Confirmation via Contemporary and Latest Techniques
- Conventional Confirmatory methods
- Gas Chromatography
- Liquid Chromatography (High Performance)
- Mass Spectrometry
- Basic Theory
- Ionization Of Electrons
- Chemical Ionization
- Full Scan Analysis
- Selected Ion Monitoring
- Quadruple Mass Spectrometer
- Quadruple ion Trap MS
- Modern Method Of Drug Confirmation
- Additional Mass Analyzers
- Time Of Flight – Mass Spectrometers
- Fticr-MS – Fourier Transform Ion Cyclotron Resonance – Mass Spectrometry
- Capillary Electrophoresis
- Summary
- Quality Assurance
- Organization Employee Assistance Programs
- Chain of Custody
- Specimen Collection
- Standard Operation Procedures
- Personnel
- Accessioning/Specimen Processing
- Security
- Internal Proficiency Testing
- External Proficiency Testing
- Inspection
- Initial and Confirmation Testing
- Equipment and Maintenance
- Laboratory Information Management System
- Records
- Specimen Validity Testing
- Quality Assurance Oversight
- Lean Six Sigma
- Summary
- Supervision of Regulated Workplace
- Historical Overview
- The Responses Of Laboratory and Regulatory Agency to the Problem
- US Federal Regulations/Criteria
- Scope of Adulterant/Substitution Products
- The HHS-Certified Laboratories Experience
- Effects of Adulterants on Analytical Tests
- Governmental Responses to the Problem
- Alternate Specimen Matrices
- Summary
- Drugs of Abuse in Hair
- Drug of Abuse in Oral Fluid
- Sweat Testing
- Amphetamines
- Opoids
- Phencyclidine
- Cocaine
- Cannabinoids
- Stability of Drugs of Abuse in Biological Fluids
- Interpretation of Workplace Drug Test Results by Medical Review Officer
- Federal Drug-Testing Programs
- Amphetamines
- Cocaine
- Marijuana
- Opiates
- Phencyclidine
- Other Drugs Tested For in Workplace Programs
- Benzodiazepines
- Barbiturates
- Methadone, Methaqualone, and Propoxyphene
- Ethyl Alcohol
- Dot-Mandated Alcohol Testing
- Specimen Validity Testing
- Additional MRO Functions Under the Federal Drug-Testing Programs
- Summary
- Laboratory Accreditation & Regulation
External Proficiency Testing
Subscription to external proficiency programs must be done by the laboratories; the program periodically sends challenge samples called proficiency test samples (PT). Prepared in the test matrix, the PT samples contain drugs or substances at specific concentrations. As expected in actual specimens, often the substances are potential interfering compounds. While the laboratory does not know the identities of the analytes and their concentration, the proficiency organization does. Instructed to test the PT using the same methods used for specimens, once the laboratory returns the tested results, the proficiency organization grades the results. Blind PT may also be submitted by some organizations. Submitted as a specimen, these samples are graded after results are returned to customers from the laboratory.
PT is sent to all certified laboratories quarterly by a single proficiency organization of the NLCP. A report is received by each laboratory, when they submit their results, which lists their results, the mean and standard deviation of all participating laboratories and their scores. Correct identification of each drug and finding its concentration within ±20% of the mean of all laboratories gives the laboratory a perfect score. Concentrations that are 20 to 50% away from the mean are termed as minor errors; reported concentrations of >50% away from the mean or incorrect identification of the drug is referred as a major error. Though required to take corrective action and return performance improvement documentation to the proficiency organization for major errors, a laboratory must investigate all errors.
Two unique QA features are provided in the external proficiency program that cannot be achieved with an internal program. First, an unbiased organization independently checks the laboratory; second, comparison of results with other laboratories in the industry is made easier. Results show that eventually all participating laboratories produce converging, acceptable, and hopefully more accurate, range of results after the initial period when external proficiency program begins and all laboratories have highly diverging results.
Previous Page---Next Page